TRIMESAPH-35

TRIMESAPH-35 Trimetazidine 35mg is used for the symptomatic treatment of stable angina pectoris in adult patients, particularly when the chest pain is not adequately controlled by other first-line anti-anginal agents. This medication is often employed as an add-on therapy to existing treatment regimens to help improve exercise tolerance and reduce the frequency of angina attacks. It works as a metabolic agent, protecting heart cells from the effects of ischemia (lack of oxygen). The 35 mg strength is a modified-release formulation designed to provide sustained therapeutic effect over a prolonged period.